Stock Screener App

Frei -

Installieren

Medical Devices

3.67

6.62% -0.26

after-market

Handel nachbörslich: 3.67

Trisalus Life Sciences Inc (TLSI)

Überblick Nachrichten Preisverlauf Forum Prognose

Trisalus Life Sciences Inc Aktie (TLSI) Neueste Nachrichten

Canaccord Genuity Group Issues Pessimistic Forecast for TriSalus Life Sciences (NASDAQ:TLSI) Stock Price - MarketBeat

MedTech Acquisition (OTCMKTS:MTACU) Files 8-K Report with SEC Announcement - Defense World

TriSalus Life Sciences Reports Strong Q3 Growth - TipRanks

TriSalus Life Sciences Inc (TLSI) Quarterly 10-Q Report - Quartzy

TriSalus Reports Q3 2024 Financial Results and Provides Business Update - BioSpace

TriSalus Life Sciences Inc (TLSI) Q3 2024 Earnings Report Previe - GuruFocus.com

TriSalus Life Sciences Inc (TLSI) Q3 2024 Earnings Report Preview: What To Look For - Yahoo Finance

Q3 Earnings Estimate for TLSI Issued By Roth Capital - MarketBeat

TriSalus Life Sciences (NASDAQ:TLSI) Upgraded by Roth Capital to "Strong-Buy" Rating - MarketBeat

Roth/MKM starts TriSalus shares coverage with Buy rating, $11 target By Investing.com - Investing.com South Africa

Roth/MKM starts TriSalus shares coverage with Buy rating, $11 target - Investing.com Canada

This GeoVax Labs Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Monday - Benzinga

TriSalus Life Sciences (NASDAQ:TLSI) Earns Buy Rating from Analysts at Roth Mkm - MarketBeat

Forms Strategic Partnership with Geo-Med, LLC to Expand Access of the TriNav - Business Wire

Reviewing TriSalus Life Sciences (TLSI) and Its Peers - Defense World

Critical Comparison: CARGO Therapeutics (CRGX) and Its Rivals - Defense World

TriSalus Life Sciences Launches TriNav® LV Infusion System and TriGuide™ Guiding Catheters, Expanding Portfolio of PEDD™ Devices for Improved Tumor Treatment - BioSpace

TriSalus Life Sciences (TLSI) to Release Quarterly Earnings on Thursday - MarketBeat

TriSalus Life Sciences (TLSI) Set to Announce Earnings on Thursday - MarketBeat

TriSalus Life Sciences (TLSI) Set to Announce Quarterly Earnings on Thursday - Defense World

TriSalus Life Sciences® Inc. Launches TriNav® LV Infusion System and TriGuide? Guiding Catheters, Expanding Portfolio of PEDD? Devices for Improved Tumor Treatment - Marketscreener.com

TriSalus Life Sciences, Inc. Announces Resignation and Departure of Board Member and Chief Medical Officer - Defense World

TriSalus Life Sciences to Host Third Quarter 2024 Financial Results Conference Call - BioSpace

Northland Securities Begins Coverage on TriSalus Life Sciences (NASDAQ:TLSI) - Defense World

Intrahepatic Cholangiocarcinoma Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, and Key Companies involved by DelveInsight | Xencor, Relay Therapeutics, Kinnate Biopharma, Forma Therapy - Barchart

Intrahepatic Cholangiocarcinoma Pipeline Update 2024: FDA - openPR

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Short Interest Up 21.3% in October - MarketBeat

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat

Northland Capmk Upgrades TriSalus Life Sciences (NASDAQ:TLSI) to "Strong-Buy" - MarketBeat

Northland initiates TriSalus shares with outperform, cites sales growth - Investing.com India

Northland initiates TriSalus shares with outperform, cites sales growth By Investing.com - Investing.com South Africa

TriSalus Life Sciences (NASDAQ:TLSI) Coverage Initiated by Analysts at Northland Securities - MarketBeat

ALUS presents the 2024 Dave Reid Award to François Allard - GlobeNewswire Inc.

Riad Salem Joins Scientific Advisory Board Of TriSalus Life Sciences - MPO-mag

Riad Salem Joins Scientific Advisory Board of TriSalus Life Sciences - MPO-mag

TriSalus Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit - BioSpace

Interventional Approaches for Locally Advanced Pancreatic Cancer - HMP Global Learning Network

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Short Interest Up 62.5% in September - MarketBeat

Bluefin Capital Management LLC Purchases New Holdings in TriSalus Life Sciences, Inc. (NASDAQ:TLSIW) - Defense World

TriSalus Life Sciences, Inc. Announces Appointment of Riad Salem to its Scientific Advisory Board - Marketscreener.com

TriSalus Life Sciences Announces Appointment of Riad Salem, M.D., to its Scientific Advisory Board - BioSpace

TriSalus Life Sciences adds oncology expert to SAB By Investing.com - Investing.com South Africa

TriSalus Life Sciences adds oncology expert to SAB - Investing.com India

Magnetar Financial LLC Has $1.05 Million Holdings in TriSalus Life Sciences, Inc. (NASDAQ:TLSIW) - Defense World

Public Sector Pension Investment Board Has $6.40 Million Stake in Arch Capital Group Ltd. (NASDAQ:ACGL) - Defense World

Terrain Minerals Welcomes New Major Investor - TipRanks

TrivarX Boosts Board with Healthcare Expertise - TipRanks

TScan therapeutics director buys $26,450 in company stock By Investing.com - Investing.com UK

Progeny 3 Inc. Raises Stock Holdings in Sixth Street Specialty Lending, Inc. (NYSE:TSLX) - Defense World

940,831 Shares in TScan Therapeutics, Inc. (NASDAQ:TCRX) Purchased by Great Point Partners LLC - Defense World

Telesis Bio Inc (TBIO) Stock: 52-Week Performance Insights and Trading Volume - The InvestChronicle

TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to “SCNX” - ForexTV.com

TRxADE Health rebrands as Scienture Holdings with new ticker SCNX - Investing.com

Investing in Telesis Bio Inc (TBIO) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News

Farallon Capital Management LLC Buys Shares of 2,000 TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World

Trupanion: Great Business, But It Is Time To Cash Out (Rating Downgrade) - Seeking Alpha

STE

$217.09

1.38%

ZBH

$113.02

0.43%

PHG

$25.95

0.43%

DXCM

$76.27

0.51%

GEHC

$82.72

1.17%

EW

$69.89

3.14%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters